DexCom CEO Kevin Sayer's 2018 pay jumps 21% to $9.6M

DexCom reports 2018 executive compensation

By ExecPay News

Published: April 19, 2019

DexCom reported fiscal year 2018 executive compensation information on April 19, 2019.
In 2018, five DexCom executives received on average a compensation package of $4.5M, a 37% increase compared to previous year.
Average pay of disclosed executives at DexCom
Kevin Sayer, Chief Executive Officer, received $9.6M in total, which increased by 21% compared to 2017. 80% of Sayer's compensation, or $7.7M, was in stock awards. Sayer also received $1.3M in non-equity incentive plan, $601K in salary, as well as $22K in other compensation.
For fiscal year 2018, the median employee pay was $80,723 at DexCom. Therefore, the ratio of Kevin Sayer's pay to the median employee pay was 118 to one.
Quentin S. Blackford, Chief Financial Officer, received a compensation package of $3.4M, which decreased by 34% compared to previous year. 68% of the compensation package, or $2.3M, was in stock awards.
Richard Doubleday, EVP, Chief Commercial Officer, earned $3.2M in 2018, a 10% increase compared to previous year.
Andrew Balo, EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development, received $3.2M in 2018, which increases by 5% compared to 2017.
Steven R. Pacelli, EVP, Strategy and Corporate Development, earned $3.2M in 2018, a 9% increase compared to previous year.

Related executives

Kevin Sayer

DexCom

Chief Executive Officer

Quentin Blackford

DexCom

Chief Financial Officer

Andrew Balo

DexCom

EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development

Richard Doubleday

DexCom

EVP, Chief Commercial Officer

Steven Pacelli

DexCom

EVP, Strategy and Corporate Development

You may also like

Source: SEC filing on April 19, 2019.